Senior Manufacturing Engineer
Instylla
Senior Manufacturing Engineer
Instylla
Interventional radiology embolic device developer
We are NOT accepting resumes from recruitment agencies or search firms.
About Instylla:
Instylla, Inc. is a privately held medical device company based in Bedford, MA, focused on developing novel resorbable embolic agents to advance interventional radiology, with initial clinical applications in interventional oncology. Instylla was founded in 2017 by Incept LLC and is funded by several leading venture capital groups. The company’s flagship product, Embrace™ Hydrogel Embolic System, is FDA-approved for hypervascular tumor embolization and offers controlled, targeted, and persistent embolization.
Position Summary/Role and Responsibilities:
The Senior Manufacturing Engineer will be responsible for overseeing Instylla’s manufacturing engineering efforts in the production of vascular embolic technologies and associated devices, ensuring product quality and scalability, driving continuous improvement initiatives, and supporting the company’s long-term growth.
Supervisory Responsibilities:
May be required to supervise Manufacturing Engineers and Technicians.
Qualifications and Education Requirements:
Knowledge/Skills:
Preferred Skills:
Working Conditions:
Instylla develops medical devices for interventional radiology, focusing on liquid embolic agents. Its flagship Embrace HES uses two low-viscosity liquid precursors that, when injected, form a PEG hydrogel to permanently block blood flow, enabling embolization of hypervascular tumors and control of arterial bleeding; the system is solvent-free, deeply penetrates the tumor bed, and provides imaging-friendly follow-up. The company differentiates itself with a solvent-free, in situ forming hydrogel that creates durable occlusion and is backed by clinical data, including FDA PMA approval in 2025, and it is also developing Tembo, a bioresorbable embolic system. Instylla aims to bring advanced embolization solutions to interventional radiologists for oncology and hemorrhage control and to broaden commercialization of next-generation embolic technologies.
Explore more opportunities at Instylla